Chris Simpson is a shareholder in Polsinelli's Venture Capital and Emerging Growth Companies Practice Group. Chris advises companies at all stages of growth, from start-ups to ready-to-IPO/exit, helping them successfully raise capital, complete acquisitions, mergers and divestitures and address day-to-day operative and commercial matters.

Venture Capital and Growth Equity

A significant portion of Chris's practice is dedicated to working with entrepreneurs and early growth stage companies, and Chris has helped countless companies navigate their way through Series Seed, A and B fundraises to exit transactions. 

Chris also counsels venture capital and growth equity funds in connection with their debt and equity financing investments in private companies. 

General Outside Counsel

Chris works as general outside counsel to private companies, with a focus on the life science and tech vertical, helping them with day-to-day legal guidance and larger strategic transactions. 

Complex Life Science Collaborations and Partnership

Chris has deep experience advising life science and life science adjacent tech companies on large complex strategic collaborations, partnerships and joint ventures.

Cross-Border Experience

A large portion of Chris's experience has involved cross-border transactions in the life sciences and tech space, including cross-border acquisitions, financings, joint ventures and collaborations. 

Before Polsinelli, Chris practiced at Choate, Hall & Stewart, LLP in Boston Massachusetts.